Philippines - English - FDA (Food And Drug Administration)

panpharma-meinz pharmaceuticals corp. - cefuroxime (as axetil) - granules for suspension - 250mg/ 5ml

Philippines - English - FDA (Food And Drug Administration)

panpharma-meinz pharmaceuticals corp. - betahistine hydrochloride - film-coated tablet - 16 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

panpharma australia pty ltd - linezolid, quantity: 600 mg - injection, solution - excipient ingredients: glucose monohydrate; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

Australia - English - Department of Health (Therapeutic Goods Administration)

panpharma australia pty ltd - linezolid, quantity: 400 mg - injection, solution - excipient ingredients: glucose monohydrate; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

Australia - English - Department of Health (Therapeutic Goods Administration)

panpharma australia pty ltd - linezolid, quantity: 200 mg - injection, solution - excipient ingredients: glucose monohydrate; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

Australia - English - Department of Health (Therapeutic Goods Administration)

panpharma australia pty ltd - caspofungin acetate -

Australia - English - Department of Health (Therapeutic Goods Administration)

panpharma australia pty ltd - caspofungin acetate -

Australia - English - Department of Health (Therapeutic Goods Administration)

panpharma australia pty ltd - daptomycin -

Australia - English - Department of Health (Therapeutic Goods Administration)

panpharma australia pty ltd - daptomycin -

Philippines - English - FDA (Food And Drug Administration)

panpharma-meinz pharmaceutical corp - ceftriaxone sodium - sodium for injection iv / im - 1g